Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Hemodynamic Monitoring Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The global hemodynamic monitoring market was valued at USD 249.06 million in 2018, and is estimated to be valued at USD 312.42 million in 2024, witnessing a CAGR of 3.85%. The key factors propelling the growth of this market are increase in the number of critically ill geriatric cases, rise in the prevalence of cardiac disorders and diabetes, increasing demand for home-based and non-invasive monitoring systems, advances in technology, due to funding by private players and government bodies, and increase in the number of people suffering from hypertension.
Scope of the Report
As per the scope of the report, critically ill patients require continuous monitoring of their vital parameters. This is done by direct pressure monitoring systems, which are also known as hemodynamic systems. The main function of these systems is to monitor the cardiac activity. The hemodynamic systems give information about blood pressure, blood volume, and fluid balance.
Key Market Trends
Minimally Invasive Monitoring Systems is Expected to hold its Highest Market Share in the System Segment
In the system segment of the market, minimally invasive monitoring systems are believed to have the largest market size and are expected to witness a CAGR of 8.0% during the forecast period.
The minimally invasive systems help in tracking stroke volume continuously and offer dynamic information of fluid responsiveness. Some of the systems provide the assessment of volumetric preload variables, while others highlight the continuous measurement of central venous saturation with proprietary catheters. These variables of minimally invasive systems, along with cardiac output, deliver improved hemodynamic monitoring.
There is a recent advancement in echocardiography device known as a transesophageal echocardiography device with a miniaturized probe, which is now used for continuous hemodynamic assessment. These monitoring systems have made hemodynamic calculations easier, which has gained the attention of healthcare providers, thus, resulting in the growth of the market.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
North America currently dominates the market for hemodynamic monitoring and is expected to continue its stronghold for a few more years. The United States holds the largest share of the global hemodynamic monitoring market. The growth of the US hemodynamic monitoring market is the most notable, owing to the presence of major market players, technologically advanced hospitals, and an increasing number of critically ill patients being treated in hospitals of the region. In 2016, Cheetah Medical Inc. received FDA approval for Starling SV’, a non-invasive hemodynamic monitoring system.
With increasing FDA approvals for monitoring devices and new product launches, the US hemodynamic monitoring market is expected to grow during the forecast period.
Competitive Landscape
The hemodynamic monitoring market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new devices with fewer prices. Companies, like Getinge Group, Koninklijke Philips NV, Edwards Life Sciences Corporation, GE Healthcare, and LiDCO Group, hold substantial shares in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Critically Ill Geriatric Population
4.2.2 Rise in the Prevalence of Cardiac Disorders and Diabetes
4.2.3 Increasing Demand for Home-based and Non-invasive Monitoring Systems
4.2.4 Advances in Technology due to Funding by Private Players and Government Bodies
4.2.5 Increasing Number of People Suffering from Hypertension
4.3 Market Restraints
4.3.1 Increasing Incidences of Complications Associated with Invasive Monitoring Systems
4.3.2 Stringent FDA Guidelines for Approval of New Systems
4.3.3 Precision of CO Determinations Adversely Affected Under Low Flow Conditions
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By System
5.1.1 Minimally Invasive Monitoring Systems
5.1.2 Invasive Monitoring Systems
5.1.3 Non-invasive Monitoring Systems
5.2 By Application
5.2.1 Laboratory-based Monitoring Systems
5.2.2 Home-based Monitoring Systems
5.2.3 Hospital-based Monitoring Systems
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 LiDCO Group PLC
6.1.2 Cheetah Medical Inc.
6.1.3 ICU Medical Inc.
6.1.4 Tensys Medical Inc.
6.1.5 Schwarzer Cardiotek GmbH
6.1.6 Koninklijke Philips NV
6.1.7 Edwards Lifesciences Corporation
6.1.8 Getinge Group
6.1.9 GE Healthcare
6.1.10 Draeger Medical
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By System
Minimally Invasive Monitoring Systems
Invasive Monitoring Systems
Non-invasive Monitoring Systems
By Application
Laboratory-based Monitoring Systems
Home-based Monitoring Systems
Hospital-based Monitoring Systems
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Tuberculosis Diagnostics Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The tuberculosis diagnostics market has witnessed a CAGR of 4.56%. Factors propelling the growth of the market include the increasing burden of tuberculosis and multidrug-resistant tuberculosis, increasing R&D investments, intensive product pipelines, and increasing government initiatives in the emerging markets.
The landscape of TB diagnostics has changed dramatically during the past ten years. Moreover, in response to WHO’s Global TB Programme, it has implemented a systematic and dynamic process, that is used to evaluate technologies and develop policies, which has, thus, enhanced the growth of the market.
The prevalence rate of tuberculosis is also increasing every year, along with the number of government awareness programs that are influencing people to opt for diagnostic tests (like radiographic tests), which are expected to drive the market during the forecast period.
The market is also expected to witness growth as there is an opportunity for players in the market studied to accelerate the market approval of their pipeline diagnostic products by spurring the fundamental research in TB. Additionally, technological developments in fields, like genomics and proteomics, can be leveraged by diagnostic providers to hasten the process of product development in TB diagnostics.
Scope of the Report
Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in emerging economies. The government initiatives for promoting diagnoses in TB are increasing globally, as governments of various regions are beginning to understand the gap areas in TB management.
Key Market Trends
Nucleic Acid Testing is expected to hold its Highest Market Share among the Diagnostic Tests
In the application type segmentation of the tuberculosis diagnostics market nucleic acid testing is believed to have the largest market size, and is expected to witness a CAGR of 5.4% during the forecast period. This can be attributed to the nucleic acid amplification tests (NAATs) that have been used as diagnostic tools for tuberculosis (TB) in the United States since many years, and which still continue to be used. There are substantial advancements in the diagnosis of TB. Moreover, hese tests have been commercially available in the United States for over two decades that offer better accuracy than other microscopy tests, and even provide greater speed than culture-based tests.
The smear laboratory test is also highly specific in areas with a very high prevalence of tuberculosis. Further, the increasing prevalence rate of TB and advancements in culture-based tests are also expected to drive the market during the forecast period.
Asia-Pacific is the Largest Regional Tuberculosis Diagnostics Market and is expected to be the Same in the Forecast Period
Asia-Pacific is anticipated to exhibit profitable growth over the forecast period due to its high burden as well the rapid proliferation of this disease. The increasing prevalence of TB in Japan helps in the growth of the TB diagnostics market, as the high prevalence of TB creates an urgent demand for effective and quick diagnosis of the disease.
In addition, according to the recent budget announcement, Government of India aims to eliminate tuberculosis (TB) by 2025, which is expected to act as a major factor for the growth of the Asia-Pacific market during the forecast period.
Competitive Landscape
The new product launches, collaborations, mergers and acquisitions, and regional expansions are the key strategic initiatives undertaken by these industry players. The major global players in the tuberculosis diagnostics market are Abbott, Becton, Dickinson and Company, BioMérieux SA, Cepheid, and F. Hoffmann-La Roche AG, among others.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Tuberculosis and Multidrug-resistant Tuberculosis (MDR-TB)
4.2.2 Increasing R&D Investments and Intensive Product Pipelines
4.2.3 Increasing Government Initiatives and Rising Awareness in the Emerging Markets
4.3 Market Restraints
4.3.1 High Costs Associated with Tuberculosis Diagnostics
4.3.2 Low Coverage or Absence of Insurance in the Emerging Markets
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Diagnostic Test Type
5.1.1 Radiographic Test
5.1.2 Laboratory Test
5.1.3 Nucleic Acid Testing
5.1.4 Cytokine Detection Test
5.1.5 Drug Resistance Test
5.1.6 Other Diagnostic Test Types
5.2 By End User
5.2.1 Hospital/Clinics
5.2.2 Diagnostics/Research Laboratory
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Becton, Dickinson and Company
6.1.3 BioMerieux SA
6.1.4 Cepheid
6.1.5 F. Hoffmann-La Roche AG
6.1.6 Hain Lifescience GmbH
6.1.7 Hologic Corporation
6.1.8 Qiagen
6.1.9 AdvaCare Pharma
6.1.10 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Diagnostic Test Type
Radiographic Test
Laboratory Test
Nucleic Acid Testing
Cytokine Detection Test
Drug Resistance Test
Other Diagnostic Test Types
By End User
Hospital/Clinics
Diagnostics/Research Laboratory
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South Americ
Hyperbaric Oxygen Therapy (HBOT) Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 111 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 111 pages
- Published: 07-06-2019
Market Overview
The hyperbaric oxygen therapy (HBOT) devices market is majorly driven by the rising prevalence of acute and chronic wounds, widening the application of HBOT devices in cosmetic procedures and wound healing, and technological advancements.
HBOT devices are used in chronic problem wounds caused by diabetes, venous or arterial insufficiency, crush injuries, and wounds/tissue damage caused by the late effects of radiation therapy. The chronic wounds impose a significant burden on the individual, the healthcare system, and the society as a whole. According to the estimates of the National Health Services (NHS), 1.5% of the UK population is estimated to have a leg ulcer. Furthermore, as per the NHS Benchmarking 2016 annual audit, approximately 39% of a district nursing service workload is attributed to wound care. The annual cost of managing wounds in the NHS and associated comorbidities has been estimated to be EUR 5.3 billion, which is more than what is on par with the obesity treatment costs, according to the study published in 2017 by Guest J, Venous Leg Ulcer Management in Clinical Practice in the UK: Costs and Outcomes. Thus, the rising incidences and prevalence of acute and chronic wounds are expected to drive the growth of the hyperbaric oxygen therapy (HBOT) devices market over the forecast period.
Scope of the Report
As per the scope of this report, the term hyperbaric oxygen therapy implicates breathing oxygen in pressurized chambers, where the atmospheric pressure is thrice higher than normal, thus, allowing the lungs to absorb three times more oxygen than in normal air pressure. Hyperbaric oxygen therapy augments the quantity of oxygen, which may improve vital tissue function in recovery from injuries and fight infection.
Key Market Trends
Monoplace HBOT is the Segment Under Application that is Expected to Grow Fastest During the Forecast Period
The monoplace HBOT segment held a maximum share in 2018, due to factors, like commercial availability of monoplace systems and high adoption of such devices, due to ease of handling and less requirement of hospital gas supply. The market is majorly dominated by few products, such as BARA-MEDXD, BARA-MED, BARA-MED Select by ETC Hyperbaric Chambers (Environmental Tectonics Corporation); PAH-S1 Hyperbaric Chamber & PAH-S1-3800 Hyperbaric Chamber by Pan-America Hyperbarics Inc.
The monoplace HBOT devices segment is expected to register a high growth rate during the forecast period, due to the rising demand for monoplace systems in hospitals and clinics, due to their higher availability in the market, along with ease in installation.
North American Region Holds the Largest Share of the Market Currently and is Believed to Follow the Same Trend over the Forecast Period
The North American region is expected to dominate the market, owing to factors, such as rising disposable income, increasing population, and the rising need for wound healing treatment, which have impelled the demand for HBOT in the region. According to the National Institutes of Health, human skin wound is a significant indirect threat to the economy, as the government takes responsibility for the treatment of the public. This has led the government to invest huge amounts of money toward developing effective treatment methods. Research in the United States has revealed that the incidence of non-healing cutaneous wounds is about 5 to 7 million per year, in the country. The relative spending for these wounds is about USD 25 billion. The cost burden to the US healthcare system has been so severe that the medical services and centers for medical care have made amendments to the reimbursement policy for wound care, providing economic incentives for hospitals, in order to improve and reduce costs. All of the aforementioned factors are expected to propel the growth of the hyperbaric oxygen therapy (HBOT) devices market.
Competitive Landscape
The hyperbaric oxygen therapy (HBOT) devices market is moderately competitive and consists of several major players. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market positions.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Acute and Chronic Wounds
4.2.2 Widening Application of HBOT Devices in Cosmetic Procedures and Wound Healing
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 High Cost of Hyperbaric Oxygen Therapy
4.3.2 Widening Gap Between Off-label Uses and FDA-approved Uses
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Application
5.1.1 Decompression Sickness
5.1.2 Diabetic Foot Ulcers
5.1.3 Gas Embolism
5.1.4 Infection Treatment
5.1.5 Wound Healing
5.1.6 Other Applications
5.2 Product Type
5.2.1 Monoplace HBOT Devices
5.2.2 Multiplace HBOT Devices
5.2.3 Topical HBOT Devices
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Environmental Tectonics Corporation
6.1.2 Fink Engineering
6.1.3 Gulf Coast Hyperbarics Inc.
6.1.4 HAUX-LIFE-SUPPORT GmbH
6.1.5 Hearmec Co. Ltd
6.1.6 Hyperbaric SAC
6.1.7 IHC Hytech BV
6.1.8 HYPERBARIC MODULAR SYSTEMS INC. (HMS)
6.1.9 Sechrist Industries Inc.
6.1.10 SOS Medical Group Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Application
Decompression Sickness
Diabetic Foot Ulcers
Gas Embolism
Infection Treatment
Wound Healing
Other Applications
Product Type
Monoplace HBOT Devices
Multiplace HBOT Devices
Topical HBOT Devices
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Netherlands In-Vitro Diagnostics Market – Growth, Trends & Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 75 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 75 pages
- Published: 07-06-2019
Market Overview
The Netherlands in vitro diagnostics market is expected to register a CAGR of approximately 5.3% over the forecast period. Major factors that are fueling this market include rapid increase in chronic diseases, increasing demand for point-of-care testing and personalized medicine, and technological advances, along with the rising geriatric population in the country.
As per a report of National Institute of Health (NIH), incidences and prevalence of chronic diseases are rapidly increasing across the world and are currently affecting more than 14 million people around the world. Furthermore, according to the World Health Organization, the prevalence rate of the overweight population in the Netherlands was 67% for men and 59% for women in 2016, and this rate is expected to increase in the coming years.
According to the European Diagnostic Manufacturers Association (EDMA), the cost of IVDs to the European healthcare systems is less than EUR 21 per person per year. In addition, patients can deal with their conditions better with the help of IVDs (diabetic patients can use portable blood glucose monitors on a regular basis to determine their blood glucose level). Therefore, the demand for IVD products is influenced by the increase in incidences of chronic diseases. As the demand for IVD is increasing, the market is growing at a faster pace.
Scope of the Report
IVDs are tests performed in laboratories or by consumers at homes, to diagnose, monitor, screen, and assess various diseases, conditions, or infections. IVD products are reagents, instruments, and systems that are intended for use in the diagnosis of diseases or other conditions. IVDs form an essential part of the current healthcare system. They reduce hospital stays and the need to recuperate.
Key Market Trends
The Point-Of-Care Diagnostics Segment is Expected to Experience the Highest CAGR Over the Forecast Period
The point-of-care (PoC) diagnostics segment of the Netherlands in vitro diagnostics market is expected to register the highest CAGR during the forecast period.
There is a significant demand for PoC diagnostics that can provide accurate and directional results. These PoC tests allow healthcare providers to begin essential treatment during visits. Many nucleic acids and immunoassay-based PoC diagnostic devices are coming close to commercialization.
Earlier, the lack of an efficient reimbursement system for the PoC technology led to the absence of both niche markets and entrepreneurial activities by large manufacturers. Hence, the Dutch government has now actively stimulated the primary diagnostic system by implementing new guidelines and lobbies. This triggered consolidation processes, entrepreneurial activities, the diagnostic market, and the performance of the IVD innovation system.
Hence, owing to the support of the government, along with the significance of PoC, the segment is expected to experience growth faster.
Competitive Landscape
The Netherlands in vitro diagnostics market has several key players, such as Roche Diagnostics, Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, and Thermo Fisher Scientific Inc., who hold large shares in this market. However, with the help of product innovation and technological advances, there is a possibility of new players entering the market in the future.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Increase in Chronic Diseases
4.2.2 Increasing Number of Private Hospitals and Independent Testing Laboratories
4.2.3 Increasing Demand for Point-of-Care Testing and Personalized Medicine
4.2.4 Technological Advances along with Rising Geriatric Population
4.3 Market Restraints
4.3.1 Price Concern
4.3.2 Stringent Regulatory Framework
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Technology
5.1.1 Clinical Chemistry
5.1.2 Immunoassays
5.1.3 Hematology
5.1.4 Coagulation and Hemostasis
5.1.5 Microbiology
5.1.6 Point-of-Care Diagnostics
5.1.7 Molecular Diagnostics
5.2 By Product
5.2.1 Instrument
5.2.2 Reagent
5.2.3 Data Management Systems and Services
5.3 By Usability
5.3.1 Disposable IVD Devices
5.3.2 Reusable IVD Devices
5.4 By End User
5.4.1 Hospitals and Clinics
5.4.2 Laboratories
5.4.3 Academics
5.4.4 Point-of-Care Testing
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Becton, Dickinson and Company
6.1.3 Bio-Rad Laboratories Inc.
6.1.4 Danaher Corporation
6.1.5 Johnson & Johnson
6.1.6 Roche Diagnostics
6.1.7 Siemens Healthcare
6.1.8 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Technology
Clinical Chemistry
Immunoassays
Hematology
Coagulation and Hemostasis
Microbiology
Point-of-Care Diagnostics
Molecular Diagnostics
By Product
Instrument
Reagent
Data Management Systems and Services
By Usability
Disposable IVD Devices
Reusable IVD Devices
By End User
Hospitals and Clinics
Laboratories
Academics
Point-of-Care Testing
Vaccine Adjuvants Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The propelling factors for the growth of the vaccine adjuvants market include the unmet needs for vaccines against certain diseases, expanding government recommendations for immunizations, technological innovations, and increasing use of recombinant subunit and synthetic vaccines.
Across the world, various governmental organizations are promoting and raising awareness regarding immunization against various diseases, like anthrax, BCG, hepatitis, HPV, influenza, varicella, smallpox, and other conditions. Thus, increasing risk of infectious diseases, effectiveness of vaccines, enhanced immunogenicity, and various government initiatives are likely to enhance the demand over the forecast period.
The adjuvant market is gaining a boost from the increasing use of recombinant subunit vaccines. As usage is increasing, the demand for various adjuvants is expanding. Over the coming years, more developments are expected to take place, increasing the need for adjuvants. The market is also expected to grow with a moderate rate, primarily fuelled by the increasing adoption of biologics and biosimilars and rising R&D in vaccines across the world.
Toxicity is the single-most crucial impediment while introducing most of the adjuvants for human use. Toxicity may also increase the financial burden on market players during the development and manufacturing phases. Thus, the negative impacts of toxicity of adjuvants on vaccine manufacturing cost and safety profiles of vaccines are hindering the growth of the market.
Also, there is an increasing demand for vaccine adjuvants, which is directly related to the growth of the vaccine market. Furthermore, market penetration in the case of developing countries remains low, presenting an opportunity for global vaccine adjuvant manufacturers to enter the emerging markets early and acquire sizable market shares.
Scope of the Report
As per the scope of the report, an adjuvant is a pharmacological or immunological agent that helps in synergizing and directing the adaptive immune response to a vaccine agent. Adjuvants are basically compounds that improve the body’s immunogenic reaction against antigens. Therefore, adjuvants are majorly added to vaccines to augment their capability to persuade long-term protection and safety against any kind of infections. Vaccine adjuvants are in the method of advancement, and currently, MF59 and aluminum salts are the only adjuvants that are feasible for human usage.
Key Market Trends
Carbohydrates adjuvants is the segment under type that is expected to grow the fastest during the forecast period
Carbohydrates are easily metabolized and generate very less toxic metabolites or long-lasting tissue deposits. Due to these advantageous reasons, their acceptance and adoption have increased since its introduction in the market. Carbohydrate adjuvants with other new types have an additional role of signaling the immune system. They boost the immune response and enhance immunogenicity.
There have also been several recent developments made in the treatment of hepatitis C virus using direct acting antivirals, which has helped researchers to shorten treatment durations and minimal side effects for patients infected with HCV. A large number of research potential and possibilities are expected over the forecast period, which may be useful for better treatment of infectious diseases and cancer treatment. Thus, the growth rate is expected to be high for this type of vaccine adjuvant.
Asia-Pacific holds the fastest growth and is expected to follow the same trend over the forecast period
Asia-Pacific is expected to witness a significant growth, due to the presence of a large population prone to various chronic and infectious diseases, such as HIV, influenza, hepatitis, and cancer. Therefore, the introduction of innovative vaccine adjuvants provides better solutions to patients at marginally lower costs. The market is growing at a significant rate, owing to the development of innovative and efficient products to meet the increasing demand from end users.
Competitive Landscape
The major companies have conducted product launches, approvals, acquisitions, and collaborations for the development of novel vaccine adjuvants, thereby, building a competitive landscape in the market. Major players are engaged in the discovery and development of new adjuvants to treat fatal diseases.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Expanding Government Recommendations for Immunizations
4.2.2 Technological Innovations
4.2.3 Unmet Vaccine Market Needs for Certain Diseases
4.2.4 Increasing Use of Recombinant Subunit and Synthetic Vaccines
4.3 Market Restraints
4.3.1 Side Effects of Adjuvants
4.3.2 High Toxicity Adjuvants
4.3.3 High R&D Cost of Developing a New Adjuvant
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Mineral Salt-based Adjuvant
5.1.2 Tensoactive Adjuvants
5.1.3 Adjuvant Emulsions
5.1.4 Liposome Adjuvants
5.1.5 Carbohydrate Adjuvants
5.1.6 Bacteria-derived Adjuvants
5.1.7 Organic Adjuvants
5.1.8 Virus-like Particles (VLP)
5.1.9 Other Types
5.2 By Route of Administration
5.2.1 Active Immunostimulants
5.2.2 Carriers
5.2.3 Vehicle Adjuvants
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Adjuvance
6.1.2 Adjuvatis
6.1.3 Brenntag AG
6.1.4 Chemtrade Logistics
6.1.5 GlaxoSmithKline
6.1.6 Invivogen
6.1.7 Merck KGaA
6.1.8 Novavax
6.1.9 Oz Biosciences
6.1.10 Seppic (Air Liquide)
6.1.11 Vaxliant
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Type
Mineral Salt-based Adjuvant
Tensoactive Adjuvants
Adjuvant Emulsions
Liposome Adjuvants
Carbohydrate Adjuvants
Bacteria-derived Adjuvants
Organic Adjuvants
Virus-like Particles (VLP)
Other Types
By Route of Administration
Active Immunostimulants
Carriers
Vehicle Adjuvants
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
UAE Dental Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 71 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 71 pages
- Published: 07-06-2019
Market Overview
The UAE dental devices market is expected to record a CAGR of approximately 6.62% over the forecast period, 2019-2024. Certain factors that are accelerating the growth of this market include increasing awareness on oral care, increasing incidences of dental diseases, and innovation in dental products in the United Arab Emirates.
Innovation in dental products has been an impactful factor that is shaping the UAE dental devices market positively.
In the past decade, the major focus in dentistry has been toward dental innovations to improve oral health through a combination of engineering, art, science, and technology. Computer Aided Design/Computer Aided Milling (CAD/CAM) is a technological innovation that has revolutionized dental care and patient experience.
A structurally damaged tooth, by decay or trauma, should be “crowned†or “cappedâ€, for it to function properly and avoid infections. A crown is a durable covering that is custom-made, usually in a dental laboratory, to fit over the entire tooth. CAD/CAM allows the manufacture of crowns immediately within the clinic or hospital. The machine makes it possible to fabricate laboratory-grade crowns and other dental restorations in minutes, whereas, the traditional crowns take two to three visits, with many weeks of waiting.
One of the most effective uses of CAD/CAM is the same-day porcelain crown, which eliminates several steps, including using a temporary plastic crown while the permanent crown is being made in the laboratory. Since people across the United Arab Emirates are more specific regarding appearance, there is an increasing demand for the dental corrections with the help of such novel methods, which in turn, is augmenting the growth of the dental devices market.
Scope of the Report
Dental instruments are tools that dental professionals use to provide dental treatment. They include tools to examine, manipulate, treat, restore, and remove teeth and surrounding oral structures. Standard instruments are the instruments used to examine, restore, and extract teeth, and manipulate tissues.
Key Market Trends
The Crown and Bridge Sub-segment in the General and Diagnostic Equipment Segment is Expected to Witness Highest Growth Rate
The crown and bridge sub-segment in the general and diagnostic equipment segment of the UAE dental devices market is expected to witness the highest CAGR during the forecast period.
A dental bridge is used to fill the gap created by one or more missing teeth. The crown or bridge is manufactured manually or with the help of CAD/CAM technology. Currently, CAD/CAM software is gaining popularity, owing to its accuracy in determining the dimensions of the crown or bridge. This software tool also speeds up the process and reduces the cost of treatment.
Owing to its significance and the adoption, there is a rise in the demand of crown and bridge in the United Arab Emirates, which is likely to contribute to the faster growth of the sub-segment in the future.
Competitive Landscape
The UAE dental devices market is moderately competitive with the inclusion of some big players, such as Carestream, Zimmer Biomet, Danaher Corporation, 3M, and Dentsply Sirona. Along with these players, there are few small companies that are also penetrating the market and holding a substantial share in it.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Awareness on Oral Care
4.2.2 Increasing Incidences of Dental Diseases
4.2.3 Innovation in Dental Products
4.3 Market Restraints
4.3.1 High Cost of the Surgeries
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 General and Diagnostic Equipment
5.1.1.1 Dental Implant
5.1.1.2 Crown and Bridge
5.1.1.3 Dental Laser
5.1.1.3.1 Soft Tissue Lasers
5.1.1.3.2 Hard Tissue Lasers
5.1.1.4 Other Product Types
5.1.2 Radiology Equipment
5.1.2.1 Extra Oral Radiology Equipment
5.1.2.2 Intra Oral Radiology Equipment
5.1.3 Dental Biomaterial
5.1.4 Dental Chair and Equipment
5.1.5 Dental Consumables
5.1.6 Other Dental Devices
5.2 By Treatment
5.2.1 Orthodontic
5.2.2 Endodontic
5.2.3 Peridontic
5.2.4 Prosthodontic
5.3 By End User
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Other End Users
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M
6.1.2 Carestream Health
6.1.3 Danaher Corporation
6.1.4 Dentsply Sirona
6.1.5 Straumann Holding AG
6.1.6 Zimmer Biomet
6.1.7 Sirona Dental Systems Inc.
6.1.8 Geistlich Holding
6.1.9 Ivoclar Vivadent AG
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product Type
General and Diagnostic Equipment
Dental Implant
Crown and Bridge
Dental Laser
Soft Tissue Lasers
Hard Tissue Lasers
Other Product Types
Radiology Equipment
Extra Oral Radiology Equipment
Intra Oral Radiology Equipment
Dental Biomaterial
Dental Chair and Equipment
Dental Consumables
Other Dental Devices
By Treatment
Orthodontic
Endodontic
Peridontic
Prosthodontic
By End User
Hospitals
Clinics
Other End Users